All News #Library
Biotech
Lapix Doses LPX-TI641 in First Atopic Dermatitis Patient
23 Dec 2025 //
GLOBENEWSWIRE
Lapix Therapeutics Announces Positive Phase 1 Data For LPX-TI641
20 Nov 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support